DEFINITIVE CONTRACT
Active75F40126C00019
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$1M
obligated · signed 4 months ago
PROPOSED RESEARCH QUALIFIES AS DEVELOPMENT (PER ITS DEFINITION IN FAR 35.001) AS PRIMARY FOCUS OF THE PROPOSED PROJECT IS ON DEVELOPING A DIGITAL TWIN MODEL, FOR EVALUATION OF BREAST CANCER IMAGING MODALITIES.
Performance timeline
Start
Jun 8, 2026
End
Jun 7, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Jun 7, 2027
MALCOVA INC
Contract 75F40126C00019
UEI
GSB6L7B1FB13
Parent Company
MALCOVA INC
Capabilities & Certifications
Headquarters Location
Congressional District: 17
Current Obligation
$1,004,344
Base + Exercised Options
$1,004,344
Total Ceiling Value
$1,004,344
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
Place of Performance
Congressional District: 17
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.